Stock A009420 HANALL BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Hanall Biopharma Co., Ltd.

Equities

A009420

KR7009420001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
37,300 KRW +2.05% Intraday chart for Hanall Biopharma Co., Ltd. +9.87% -15.80%
May. 03 HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease CI
Mar. 06 Hanall Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Hanall Biopharma Co., Ltd.

80c19cd1e7dc7097042f883d28490.3Pg7iL_9_WfjBMvfk1VF_G8Ar6l5xd1QLPWpQspWHqY.q4xO_MeMlQmva7uZpR8mqQhZ2cNAqKdiVJDlF7IOePbqm3DYiK2VUIRWmg~820b2bd5ea6aaef59cfcb0bb95ef767f

Upcoming events on Hanall Biopharma Co., Ltd.

2024-08-13 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-04-06 Q4 2024 Earnings Release (Projected)
2025-04-29 Q1 2025 Earnings Release (Projected)

Past events on Hanall Biopharma Co., Ltd.

2024-04-30 07:00 am Q1 2024 Earnings Release
2024-03-21 07:00 am Q4 2023 Earnings Release
2024-01-07 JPMorgan Healthcare Conference
2024-01-06 Sachs Associates Neuroscience Innovation Forum
2023-10-26 07:00 am Q3 2023 Earnings Release
2023-07-27 07:00 am Q2 2023 Earnings Release
2023-04-28 07:00 am Q1 2023 Earnings Release
2023-02-01 07:00 am FY 2022 Earnings Release
2022-11-13 Q3 2022 Earnings Release
2022-08-15 Interim 2022 Earnings Release
2022-01-20 09:00 am FY 2021 Sales and Revenue Release
2021-10-26 Q3 2021 Sales and Revenue Release
2021-08-16 Interim 2021 Earnings Release
2021-07-29 06:44 am Interim 2021 Sales and Revenue Release
2021-05-06 04:00 am Q1 2021 Earnings Release
2021-01-18 FY 2020 Earnings Release
2020-03-29 FY 2019 Earnings Release
2019-11-13 Q3 2019 Earnings Release
2019-05-14 Q1 2019 Earnings Release
2018-08-12 Interim 2018 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		108
109
-0.26%		88,6
103
-13.89%		102
102
-0.3%		110
110
0.09%		135
137
-1.23%
144

EBITDA
Billions KRW		Released
Forecast
Spread 		19,8
22,3
-11.27%		8,83
25,4
-65.24%		12,8
15,8
-18.84%		4,56
8,00
-43.02%		0,00
11,2
-
7,00

EBIT
Billions KRW		Released
Forecast
Spread 		17,1
16,9
1.36%		5,94
14,4
-58.69%		10,1
11,9
-15.13%		1,51
5,20
-71.04%		2,21
7,63
-71.03%
3,60

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		17,5
18,5
-5.82%		19,6
22,4
-12.43%		8,70
13,3
-34.57%		1,93
5,00
-61.42%		3,20
9,13
-64.94%
5,86

Net income
Billions KRW		Released
Forecast
Spread 		19,2
16,7
15.05%		19,8
22,0
-10.16%		10,00
14,6
-31.51%		1,99
5,50
-63.85%		3,51
7,13
-50.81%
2,60

EPS
KRW		Released
Forecast
Spread 		375
318
17.8%		386
418
-7.66%		174
279
-37.63%		5,00
106
-95.28%		69,0
138
-49.96%
52,0

Announcement Date16/01/2019/01/2118/01/2219/01/2324/01/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Billions KRW		Released
Forecast
Spread 		24,9
25,9
-3.92%		24,0
24,9
-3.67%		26,2
32,8
-19.97%		29,6
29,6
0.14%		30,1
30,1
0.05%		28,8
37,8
-23.8%		41,4
31,1
33.28%		33,0
33,1
-0.24%		31,7
36,0
-11.89%		34,1



34,4


37,5


35,9

EBITDA
Billions KRW		Released
Forecast
Spread

















8,59
2,00
329.43%		0,67
1,20
-43.94%
-0,10













EBIT
Billions KRW		Released
Forecast
Spread 		0,92
2,60
-64.45%		-0,59
1,20
-149.33%		0,68
6,80
-89.98%		0,62
0,60
3.64%		0,79
4,50
-82.35%		-1,74
10,8
-116.1%		8,00
2,33
242.73%		0,10
1,05
-90.48%		-4,26
5,00
-185.27%



0,40


1,40


1,80

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		0,30
3,90
-92.18%		-0,01
1,20
-101.24%		0,58
6,50
-91.09%		0,73
0,70
4.91%		0,63
4,80
-86.86%


8,20
0,00
- 		0,51
0,20
155.39%














Net income
Billions KRW		Released
Forecast
Spread 		-0,95
3,80
-125.01%		-0,08
1,40
-105.93%		-0,08
5,80
-101.33%		0,73
0,70
4.91%		-0,32
4,90
-106.59%		-1,25
8,60
-114.58%		7,31
0,90
711.83%		0,30
1,08
-72.09%		-2,86
3,00
-195.44%		-0,30



0,60


1,30


1,60

Announcement Date18/01/2228/04/2216/08/2229/11/2219/01/2315/05/2326/07/2326/10/2324/01/2430/04/24---

Upcoming sector events for Hanall Biopharma Co., Ltd.

2024-05-19 TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release
2024-05-21 CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release (Projected)
2024-05-21 GLAND PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-22 ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release (Projected)
2024-05-23 TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-26 NATCO PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-26 DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release (Projected)
2024-05-27 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
2024-05-28 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-28 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release (Projected)
More events

Past sector events for Hanall Biopharma Co., Ltd.

2024-05-16 J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-16 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-15 10:05 am MANKIND PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-15 01:30 am DERMAPHARM HOLDING SE: Q1 2024 Earnings Release
2024-05-15 07:40 am CRESCO LABS INC.: Q1 2024 Earnings Release
2024-05-15 03:03 am GRANULES INDIA LIMITED: Q4 2024 Earnings Release
2024-05-14 EISAI CO., LTD.: Q4 2023 Earnings Release
2024-05-14 05:43 pm LIQUIDIA CORPORATION: Q1 2024 Earnings Release
2024-05-14 04:52 am BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release
2024-05-14 01:30 am BAYER AG: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A009420 Stock
  4. Calendar Hanall Biopharma Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW